NASDAQ : NGNE

Neurogene Inc.

$38.17 USD

$1.67 (4.58%)

Volume
317.5K
Average Volume
210.95K
Market Capitalization
$603.17M
P/E Ratio
-7.59
Dividend Yield
0.00%
Price Target
$70.00
Year High
$43.66
Year Low
$15.93
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$13.08
NGNE vs. The Competition
Properties NGNE ADCT ALMS AUTL
Market Cap $603.17M $170.44M $3.56B $384.58M
Shares Outstanding $15.8M $127.19M $123.43M $266.14M
P/E Ratio -7.59 -1.27 -15.08 -1.33
EPS -4.42 -0.89 -1.9 -1.09
Day Low 35.11 1.31 26.69 1.42
Day High 38.17 1.46 28.96 1.47
Year Low 15.93 0.78 3.245 1.175
Year High 43.66 4.98 31.35 2.7
Average Price 50 31.146 2.09828 24.0011 1.6094
Average Price 200 24.64628 3.51482 18.65825 1.5439
Volume 317.5K 1.21M 726.98K 687.67K
Average Volume - - - -
NGNE Top Competitors
Symbol Name Last Change %Chg Volume
ADCT ADC Therapeutics S.A. $1.34 -0.00999997 -0.74% 1.21M
ALMS Alumis Inc. $28.81 1.58 5.80% 726.98K
AUTL Autolus Therapeutics plc $1.445 -0.015 -1.03% 687.67K